Simplex Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-598
Closed -$184K 7349
2016
Q4
$184K Buy
598
+57
+11% +$686 0.01% 1106
2016
Q3
$139K Buy
541
+307
+131% +$3.08K 0.01% 1297
2016
Q2
$10K Sell
234
-242
-51% -$1.82K ﹤0.01% 3648
2016
Q1
$24K Sell
476
-1,828
-79% -$10.2K ﹤0.01% 2657
2015
Q4
$187K Buy
2,304
+1,281
+125% +$8.41K 0.01% 924
2015
Q3
$51K Buy
1,023
+870
+569% +$6.7K ﹤0.01% 1992
2015
Q2
$5K Buy
153
+5
+3% +$44 ﹤0.01% 3741
2015
Q1
$12K Sell
148
-608
-80% -$4.5K ﹤0.01% 2832
2014
Q4
$95K Buy
+756
New +$4.73K 0.01% 959

Other funds holding ARIA

Simplex Trading's ARIA Position: Q1 2017 in Review

Simplex Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 38,420 shares — an estimated $477K sold.

Simplex Trading first reported a position in ARIA in Q1 2015 and held it in 6 quarters. The position peaked at $1.31M in Q2 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Simplex Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Simplex Trading sold 38,420 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $477K.
  • Simplex Trading first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and held it in 6 quarters.
  • Simplex Trading's Ariad Pharmaceuticals Inc position peaked at $1.31M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Simplex Trading's 13F filing for Q1 2017, filed 21 Apr 2017.